Notable Research Findings

The most groundbreaking individual studies from the latest supplement and nutrition research — in plain language, with the evidence caveats built in. Research signals worth knowing about, not health advice.

A 180-day trial found a blend of four herbs — including milk thistle — improved liver enzymes in healthy adults, but the effect can't be pinned on thistle alone.
- 2026-01-23
- Clinical Trial
- n = 130
- Frontiers in nutrition
This is the first solid clinical trial linking milk thistle (as part of a mix) to lower alkaline phosphatase, but the combination product means we don't know how much thistle contributed — and the overall evidence for thistle alone on this marker is still modest and based on small effects.
New evidenceThistle for Reduced Alkaline Phosphatase Level
Red grape flavonoids significantly lowered a liver enzyme in NAFLD patients — but didn't touch inflammation or scarring
- 2025-09-15
- Systematic Review
- n = 689
- Frontiers in nutrition
This meta-analysis of 689 people with fatty liver disease found a moderate, consistent drop in AST (a marker of liver stress), but the benefit stopped there — inflammatory markers and fibrosis scores didn't budge, and the evidence rests on only four studies, so the picture is promising but far from settled.
Big effectRed Grape for Reduced Aspartate Aminotransferase Level
A probiotic blend doubled the response rate for IBS symptoms at 28 days — but the benefit came from two strains together, not BB-12 alone, and the overall gut microbiome barely budged.
- 2025-11-18
- RCT
- Journal of gastroenterology and hepatology
This is one of the first rigorous trials on this specific probiotic pairing, so the results are promising but far from settled — the real-world impact depends on whether the combination, not just BB-12, drives the effect, and other measures like overall microbiome composition didn't change.
Big effectBifidobacterium animalis subsp. lactis BB-12 for Improved Irritable Bowel Syndrome Symptoms
A live Lactobacillus crispatus product significantly reduced bacterial vaginosis recurrence — but efficacy was incomplete and hinged on baseline microbiota.
- 2026-04
- RCT
- Cell host & microbe
This is one of the first rigorous trials to show that a specific Lactobacillus strain can prevent BV recurrence, but the incomplete effect and novelty mean it's not yet a proven solution for everyone.
Big effectLactobacillus crispatus for Reduced Recurrence of Bacterial Vaginosis
Adding saw palmetto to a standard BPH drug outperformed the drug alone in a 12-month trial — but the extra benefit only kicked in after three months, and the study didn't test saw palmetto by itself.
- 2025-10-16
- RCT
- The Prostate
This study suggests saw palmetto may have a role as an add-on therapy for men already taking alfuzosin for enlarged prostate symptoms, but it doesn't change the overall weak evidence for saw palmetto as a standalone treatment — and the trial's design (unclear blinding and funding) means the result should be weighed cautiously.
Myth-busterSaw Palmetto for Improved Lower Urinary Tract Symptoms
A probiotic reduced dry eye symptom scores in a 68-person trial — but the effects were tied to a single strain and haven't been replicated yet.
- 2025-04-10
- RCT
- n = 68
- Biomedicines
This is the first controlled trial linking Streptococcus thermophilus iHA318 to dry eye relief, so while the results are promising, they come from a small, single study that needs independent confirmation before you can count on it.
New evidenceStreptococcus thermophilus SL-21 for Improved Dry Eye Symptoms
A 12-week trial added a specific Bifidobacterium strain to metformin and saw a statistically significant drop in HbA1c — but only in a small, early study on type 2 diabetes patients.
- 2026-01
- RCT
- Food science & nutrition
This is the first randomized trial to show that Bifidobacterium longum subsp. longum BL21 might help lower blood sugar control marker HbA1c in type 2 diabetes, but it's a single early result in a specific clinical population — so treat it as promising but far from proven.
New evidenceBifidobacterium longum subsp. longum for Improved Glycemia
A systematic review found Lactobacillus rhamnosus TOM 22.8 at 10×10⁹ CFU/day for 10 days significantly reduced bacterial vaginosis recurrence — but only one strain had strong data, and the optimal dose is still unclear.
- 2025-03-10
- Systematic Review
- Narra J
This is among the first indexed reviews on this exact strain-dosing combination, so while the result is promising for recurrence prevention, it's a single early signal — not a settled recommendation.
New evidenceLactobacillus jensenii LBV 116 for Reduced Recurrence of Bacterial Vaginosis
In a 12-week trial, a Bifidobacterium infantis strain slashed respiratory infection incidence to 15% versus 42% in preschoolers — but the effect comes from a single, early study.
- 2026-01-05
- Clinical Trial
- Frontiers in nutrition
This large effect size is eye-catching, but because it's one of the first trials on this specific pairing, the result needs replication before we can trust it broadly — especially in adults or other age groups.
Big effectBifidobacterium infantis for Reduced Respiratory Infections
A placebo-controlled trial found a yogurt bacterium significantly reduced gut symptom scores — and also linked it to better sleep and immune markers, though these extra findings come from a single early study.
- 2026-01
- RCT
- Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
This is among the first human trials on this specific probiotic strain, so while the gut symptom improvement is statistically significant, the broader claims about sleep and immunity are less certain and need independent replication.
SurprisingLactobacillus bulgaricus LB42 for Improved Gastrointestinal Symptoms
Curcumin associated with healthier cholesterol in a new umbrella review — but the studies it pooled were too weak to be convincing
- 2025-06-05
- Systematic Review
- Frontiers in pharmacology
This review suggests curcumin may improve lipid profiles, but because the included trials had poor methodological quality, the finding is far from definitive. It's one of the first comprehensive looks at curcumin and cholesterol, so more high-quality research is needed.
TrendingTurmeric for Improved Blood Lipid Profile
Chanca Piedra as an add-on to shockwave therapy improved stone clearance for lower pole kidney stones — but this is the first systematic review on the combo, so the evidence is still early and the dose wasn't specified.
- 2025-07
- Systematic Review
- Actas urologicas espanolas
This systematic review is the first to compile data on Chanca Piedra specifically as an adjunct to ESWL for lower pole stones, making the finding promising but preliminary — the exact dose remains unknown, and the overall body of evidence on this pairing is still thin.
New evidenceChanca Piedra for Improved Stone-Free State
Red sage cut creatinine and multiple inflammation markers in 1,970 people with diabetic kidney disease — but this is the first meta-analysis on the pairing, so the picture is far from settled.
- 2025-09-12
- Systematic Review
- n = 1,970
- Frontiers in pharmacology
This is the first solid systematic review linking red sage (Salvia miltiorrhiza) to kidney protection in diabetics, but because the evidence is still early and the underlying 21 trials varied in quality, the result is promising — not definitive.
New evidenceRed Sage for Reduced Serum Creatinine Levels
Caffeine plus taurine beat either alone for anaerobic capacity in a meta-analysis — but the same review found no boost to endurance or athletic performance.
- 2025-10
- Systematic Review
- Journal of the International Society of Sports Nutrition
This is the first systematic analysis to suggest a real synergy between caffeine and taurine for short bursts of effort, but with no effect on other fitness measures and no prior studies to lean on, one meta-analysis does not make a settled fact.
New evidenceTaurine for Improved Anaerobic Capacity
A meta-analysis found that toothpaste containing Bifidobacterium animalis BS-01 reduced plaque by a moderate amount after 3 months — but the studies behind it varied so much that the true effect is uncertain.
- 2025-10-20
- Systematic Review
- Frontiers in oral health
This is the first solid evidence linking this specific probiotic to better oral health, but with only one meta-analysis and high inconsistency across the included studies, it's too early to treat this as a reliable benefit.
New evidenceBifidobacterium animalis BS-01 for Improved Plaque Index
Quercetin ranked highest among plant compounds for reducing RA pain in a meta-analysis — but the evidence is still sparse.
- 2025-02-05
- Systematic Review
- Frontiers in pharmacology
This analysis suggests quercetin may be the most effective plant compound for pain relief in rheumatoid arthritis, but with few studies and no specified dose, it's far from a proven treatment.
TrendingQuercetin for Reduced Visual Analog Scale Score
Portulaca oleracea (purslane) raised urinary citrate and lowered calcium in a systematic review of kidney stone studies — but the evidence is still thin.
- 2025-10-20
- Systematic Review
- Naunyn-Schmiedeberg's archives of pharmacology
This is among the first indexed studies to look at purslane for kidney stone risk, so while the direction is promising, a single systematic review of small trials isn't enough to act on yet.
New evidencePortulaca for Increased Urinary Citrate Level
Probiotics cut UTI recurrence risk in kids — but an adult study found minimal effect, highlighting age-specific results.
- 2025-11-26
- Systematic Review
- Annals of medicine and surgery (2012)
This systematic review offers early evidence that Bifidobacterium bifidum HA-132 and other probiotics may help reduce UTI recurrence in children, but the finding is limited by mixed results in adults and the fact that this is among the first indexed studies on this specific pairing — so treat it as promising but far from settled.
New evidenceBifidobacterium bifidum HA-132 for Reduced Recurrence of Urinary Tract Infections
Berberine cut triglycerides by roughly 0.37 mmol/L in a meta-analysis of 4 trials — but only 2 of those studies saw a benefit, leaving the overall evidence low.
- 2025-07-16
- Systematic Review
- Frontiers in pharmacology
This pooled result is a signal worth watching, not a settled fact: a systematic review found berberine lowered triglycerides, fasting glucose, and waist circumference in metabolic syndrome, yet half the individual studies saw no effect, and the overall evidence grade is weak.
TrendingBerberine for Reduced Triglyceride Levels
Gymnema mints cut sugar-sweetened beverage intake by 42% in a 14-day trial — but the study was single-blind and among the first to test this pairing.
- 2025-03
- RCT
- Appetite
This is a promising early signal that Gymnema may help curb sweet cravings, but the evidence is thin — the study was small, single-blind, and hasn't been replicated, so treat the 42% reduction as a reason to watch for more data rather than a proven effect.
Big effectGymnema for Reduced Sugar-Sweetened Beverage Intake
A meta-analysis of Japanese studies linked habitual natto intake to modestly greater bone density (d = 0.65) — but the certainty of the evidence was low, and nearly all data came from observational research.
- 2025-11-28
- Systematic Review
- Frontiers in nutrition
This is the first systematic review on natto and bone density, but because it mostly pools observational studies with moderate-to-low certainty, think of it as a suggestive signal — not a settled finding — that needs confirmation in controlled trials.
New evidencenatto for Increased Bone Mineral Density
Zinc cut infection risk by 32% in a new umbrella review — but the same analysis flagged vitamin D with a more modest 12% reduction, and both findings rest on a body of evidence still thin enough to treat as preliminary.
- 2025-12-01
- Systematic Review
- Journal of preventive medicine and hygiene
This is among the first broad looks at these specific nutrient–infection pairs, so the numbers are intriguing but far from settled — expect future studies to shift the estimates.
New evidenceVitamin D for Reduced Infection Rate
Anthocyanidins linked to 16% lower digestive cancer risk — but this is an early umbrella review, not a final answer
- 2026
- Systematic Review
- Expert reviews in molecular medicine
This is the first systematic summary to tie anthocyanidins specifically to a reduced risk of digestive system cancers, but because it's an umbrella review of existing meta-analyses, the quality of the underlying studies varies, and the result needs independent replication before it can be considered reliable.
New evidenceAnthocyanins for Reduced Risk of Digestive System Cancer
B vitamins lowered homocysteine by 2.36 µmol/L in heart patients — but didn't reduce heart attacks or deaths.
- 2026-01-30
- Meta-Analysis
- n = 539
- Annals of medicine
This meta-analysis confirms that combined B9, B6, and B12 supplementation reliably drops homocysteine, yet that lab improvement didn't translate into fewer major cardiovascular events — a reminder that a biomarker win isn't always a clinical win.
Myth-busterVitamin B9 for Reduced Homocysteine Level
In a pediatric obesity review, L-carnitine beat other supplements for cutting BMI and waist size — but the findings come from a clinical population that may not reflect everyday use.
- 2026-02-12
- Systematic Review
- Frontiers in nutrition
This is the strongest signal yet for L-carnitine on weight and metabolic markers, but it's based on moderate-strength evidence from only six studies in a clinical pediatric setting, so don't assume the same effect in healthy adults supplementing on their own.
Big effectL-Carnitine for Reduced Body Mass Index
Pomegranate consumption tied to a 0.63 standard deviation drop in a blood vessel inflammation marker — but the finding rests on just three clinical trials.
- 2025-04-28
- Meta-Analysis
- Journal of dietary supplements
This meta-analysis provides the first pooled evidence that pomegranate may reduce ICAM-1, a sign of endothelial inflammation, but the small number of trials and missing dose details mean the effect is preliminary and far from settled.
New evidencepomegranate for Reduced Soluble Intercellular Adhesion Molecule-1 Level
Chamomile reduced mucositis severity across 11 trials — but the studies were too small and varied to say how much.
- 2025-07-15
- Meta-Analysis
- n = 11
- Pharmaceutical biology
This meta-analysis suggests chamomile may help with mouth sores from cancer treatment, but because the 11 trials were small and the dose wasn't standardized, the evidence is still too weak to act on.
SurprisingChamomile for Reduced Mucositis Severity
Heat-killed probiotics boosted villus height and crypt depth in broiler intestines — but only at a higher dose, and growth performance didn't budge.
- 2025-09
- RCT
- n = 300
- Veterinary and animal science
This is one of the first controlled trials to show that non-living probiotics can measurably alter gut structure in chickens, but with no prior human data on this specific preparation, it's a promising early signal — not a recommendation.
New evidenceBacillus subtilis AB22 for Improved Intestinal Morphology
Weekly 15,000 IU vitamin D for lactating mothers boosted infant blood levels by 14.7 nmol/L — yet the same trial found no reduction in rickets or improvement in growth or motor development.
- 2025-11
- RCT
- The American journal of clinical nutrition
While the study reinforces that vitamin D supplementation effectively raises blood levels (a pattern seen across three prior trials), the lack of any clinical benefit for rickets, growth, or motor skills in these infants cautions against assuming that correcting a biomarker automatically improves health outcomes in this population.
Myth-busterVitamin D for Improved Vitamin D Levels
A duck study found that *Lactobacillus acidophilus* LA-02 boosted weight gain and feed efficiency — but the evidence comes from a single trial in birds, not humans.
- 2026-05
- RCT
- n = 180
- Poultry science
This is the first solid test of this specific probiotic for growth, but with only one study on ducks and no human data yet, it’s a lead to watch — not a recommendation.
New evidenceLactobacillus acidophilus LA-02 for Improved Growth Performance